English

Arcturus Therapeutics Holdings Inc.

EDGAR

ARCT Quarterly report (10-Q) · filed 2026-08-06

Annual consolidated revenue for 2025: about USD 82.03M, using the latest reported figures. The previous period, 2024, was about USD 152.3M.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

2.96 million USD

2026 Q2 · USD

Exact inputs and evidence

Revenue: 2959000 USD Source

Operating margin

-863.3%

2026 Q2 · %

Exact inputs and evidence

Operating Income: -25545000 USD Source
Revenue: 2959000 USD Source

Operating cash flow

-19.9 million USD

2026 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -39351000 USD Source
Operating Cash Flow: -19441000 USD Source

Free cash flow

-19.9 million USD

2026 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -39351000 USD Source
Operating Cash Flow: -19441000 USD Source
Capital Expenditure: 0 USD Source
Capital Expenditure: 0 USD Source

Cash and cash equivalents: 191 million USD 2026-06-30 Source
Exact value

191483000 USD
Long-term debt including current maturities: 13.3 million USD 2022-09-30 Source
Exact value

13300000 USD
Shares outstanding: 28.4 million shares 2026-06-30 Source
Exact value

28423000 shares

Reported share-count change

4.70% · 1.28 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

27148000 shares · 2025-06-30· Source
28423000 shares · 2026-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

29.4 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Revenue: 17151000 USD · 2025-07-01 – 2025-09-30 Source
Revenue: 82031000 USD · 2025-01-01 – 2025-12-31 Source
Revenue: 74835000 USD · 2025-01-01 – 2025-09-30 Source
Revenue: 2061000 USD · 2026-01-01 – 2026-03-31 Source
Revenue: 2959000 USD · 2026-04-01 – 2026-06-30 Source

Net income

-93.3 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Net income: -13448000 USD · 2025-07-01 – 2025-09-30 Source
Net income: -65783000 USD · 2025-01-01 – 2025-12-31 Source
Net income: -36704000 USD · 2025-01-01 – 2025-09-30 Source
Net income: -26964000 USD · 2026-01-01 – 2026-03-31 Source
Net income: -23785000 USD · 2026-04-01 – 2026-06-30 Source

Operating cash flow

-72.7 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Operating cash flow: -58044000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -40893000 USD · 2025-01-01 – 2025-06-30 Source
Operating cash flow: -74271000 USD · 2025-01-01 – 2025-12-31 Source
Operating cash flow: -58044000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -19441000 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: -39351000 USD · 2026-01-01 – 2026-06-30 Source
Operating cash flow: -19441000 USD · 2026-01-01 – 2026-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-08-06.

Financial data available through: 2025-12-31.

Coverage by financial measure

Revenue: 8 of 11 periods available· newest 2025-12-31
Operating income: 8 of 11 periods available· newest 2025-12-31
Net income: 8 of 11 periods available· newest 2025-12-31
Operating cash flow: 8 of 11 periods available· newest 2025-12-31
Capital expenditure: 8 of 11 periods available· newest 2025-12-31
Total assets: 8 of 11 periods available· newest 2025-12-31
Total liabilities: 8 of 11 periods available· newest 2025-12-31
Current assets: 8 of 11 periods available· newest 2025-12-31
Current liabilities: 8 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 8 of 11 periods available· newest 2025-12-31
Long-term debt including current maturities: 3 of 11 periods available· newest 2021-12-31
Shares outstanding: 8 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-46.1%

Prior period

USD 152.31 million

2024-01-01 – 2024-12-31
Current period

USD 82.03 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

82031000 − 152310000 = -70279000 USD

152310000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
82031000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Arcturus Therapeutics Holdings Inc. · 2025-12-31 Arcturus Therapeutics Holdings Inc. (edgar:1768224) Year-over-year change in Revenue: -70279000 USD Concept: fundies:Revenue Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1768224?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 82031000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1768224/000119312526088391/arct-20251231.htm#2935108 Filing: 000119312526088391 Input fundies:Revenue: 152310000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1768224/000119312526088391/arct-20251231.htm#2936778 Filing: 000119312526088391
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 15.16 million

Prior period

−USD 80.94 million

2024-01-01 – 2024-12-31
Current period

−USD 65.78 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-65783000 − -80941000 = 15158000 USD

-80941000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-65783000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Arcturus Therapeutics Holdings Inc. · 2025-12-31 Arcturus Therapeutics Holdings Inc. (edgar:1768224) Year-over-year change in Net income: 15158000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1768224?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -65783000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1768224/000119312526088391/arct-20251231.htm#3008865 Filing: 000119312526088391 Input fundies:NetIncome: -80941000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1768224/000119312526088391/arct-20251231.htm#3010722 Filing: 000119312526088391
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 14.52 million

Prior period

−USD 59.75 million

2024-01-01 – 2024-12-31
Current period

−USD 74.27 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-74271000 − -59747000 = -14524000 USD

-59747000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-74271000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Arcturus Therapeutics Holdings Inc. · 2025-12-31 Arcturus Therapeutics Holdings Inc. (edgar:1768224) Year-over-year change in Operating cash flow: -14524000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1768224?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -74271000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1768224/000119312526088391/arct-20251231.htm#1927949 Filing: 000119312526088391 Input fundies:OperatingCashFlow: -59747000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1768224/000119312526088391/arct-20251231.htm#1929700 Filing: 000119312526088391
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-64.5%

Prior period

USD 648,000

2024-01-01 – 2024-12-31
Current period

USD 230,000

2025-01-01 – 2025-12-31

Exact inputs and evidence

230000 − 648000 = -418000 USD

648000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
230000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Arcturus Therapeutics Holdings Inc. · 2025-12-31 Arcturus Therapeutics Holdings Inc. (edgar:1768224) Year-over-year change in Capital expenditure: -418000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1768224?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 230000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1768224/000119312526088391/arct-20251231.htm#1937247 Filing: 000119312526088391 Input fundies:CapitalExpenditure: 648000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1768224/000119312526088391/arct-20251231.htm#1938986 Filing: 000119312526088391
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

Revenue USD 82.03 million 100% of revenue
Operating costs Derived USD 158.29 million 193% of revenue
Operating income −USD 76.26 million −93% of revenue
Tax, interest and other Derived −USD 10.48 million −13% of revenue
Net income −USD 65.78 million −80% of revenue

Cash

Operating cash flow −USD 74.27 million −91% of revenue
Capital expenditure USD 230,000 0.3% of revenue
Free cash flow Derived −USD 74.5 million −91% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2018 Operating loss: operating costs were 238% of revenue.
2019 Operating loss: operating costs were 223% of revenue.
2020 Operating loss: operating costs were 850% of revenue.
2021 Operating loss: operating costs were 1,741% of revenue.
2022 94%
2023 Operating loss: operating costs were 147% of revenue.
2024 Operating loss: operating costs were 163% of revenue.
2025 Operating loss: operating costs were 193% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2018 2018-01-01 – 2018-12-31	15753000	37564000 Derived	-21811000	-26000 Derived	-21785000	-22238000 Derived	Source 2018-01-01 – 2018-12-31: 15753000 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -21811000 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -21785000 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: -20760000 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 1478000 USD Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	20789000	46302000 Derived	-25513000	478000 Derived	-25991000	-7263000 Derived	Source 2019-01-01 – 2019-12-31: 20789000 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -25513000 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -25991000 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: -6445000 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 818000 USD Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	9539000	81063000 Derived	-71524000	624000 Derived	-72148000	-44603000 Derived	Source 2020-01-01 – 2020-12-31: 9539000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -71524000 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -72148000 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: -42861000 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 1742000 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	12359000	215211000 Derived	-202852000	822000 Derived	-203674000	-138449000 Derived	Source 2021-01-01 – 2021-12-31: 12359000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -202852000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -203674000 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -135043000 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 3406000 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	205999000	193822000 Derived	12177000	2828000 Derived	9349000	24267000 Derived	Source 2022-01-01 – 2022-12-31: 205999000 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: 12177000 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: 9349000 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: 31993000 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 7726000 USD Inspect Capital Expenditure Open source
2023 2023-01-01 – 2023-12-31	166799000	245004000 Derived	-78205000	-48480000 Derived	-29725000	-21000000 Derived	Source 2023-01-01 – 2023-12-31: 166799000 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: -78205000 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -29725000 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: -18099000 USD Inspect Operating Cash Flow Open source 2023-01-01 – 2023-12-31: 2901000 USD Inspect Capital Expenditure Open source
2024 2024-01-01 – 2024-12-31	152310000	247979000 Derived	-95669000	-14728000 Derived	-80941000	-60395000 Derived	Source 2024-01-01 – 2024-12-31: 152310000 USD Inspect Revenue Open source 2024-01-01 – 2024-12-31: -95669000 USD Inspect Operating Income Open source 2024-01-01 – 2024-12-31: -80941000 USD Inspect Net Income Open source 2024-01-01 – 2024-12-31: -59747000 USD Inspect Operating Cash Flow Open source 2024-01-01 – 2024-12-31: 648000 USD Inspect Capital Expenditure Open source
2025 2025-01-01 – 2025-12-31	82031000	158291000 Derived	-76260000	-10477000 Derived	-65783000	-74501000 Derived	Source 2025-01-01 – 2025-12-31: 82031000 USD Inspect Revenue Open source 2025-01-01 – 2025-12-31: -76260000 USD Inspect Operating Income Open source 2025-01-01 – 2025-12-31: -65783000 USD Inspect Net Income Open source 2025-01-01 – 2025-12-31: -74271000 USD Inspect Operating Cash Flow Open source 2025-01-01 – 2025-12-31: 230000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 82M 2025

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20182018-12-31	Revenue	15753000	Revenue: 15753000 Open source
20192019-12-31	Revenue	20789000	Revenue: 20789000 Open source
20202020-12-31	Revenue	9539000	Revenue: 9539000 Open source
20212021-12-31	Revenue	12359000	Revenue: 12359000 Open source
20222022-12-31	Revenue	205999000	Revenue: 205999000 Open source
20232023-12-31	Revenue	166799000	Revenue: 166799000 Open source
20242024-12-31	Revenue	152310000	Revenue: 152310000 Open source
20252025-12-31	Revenue	82031000	Revenue: 82031000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-46.1% 2025

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20182018-12-31	Year over year	No prior comparable period	Revenue: 15753000 Open source
20192019-12-31	Year over year	32%	Revenue: 20789000 Open source Revenue: 15753000 Open source
20202020-12-31	Year over year	-54.1%	Revenue: 9539000 Open source Revenue: 20789000 Open source
20212021-12-31	Year over year	29.6%	Revenue: 12359000 Open source Revenue: 9539000 Open source
20222022-12-31	Year over year	1,566.8%	Revenue: 205999000 Open source Revenue: 12359000 Open source
20232023-12-31	Year over year	-19%	Revenue: 166799000 Open source Revenue: 205999000 Open source
20242024-12-31	Year over year	-8.7%	Revenue: 152310000 Open source Revenue: 166799000 Open source
20252025-12-31	Year over year	-46.1%	Revenue: 82031000 Open source Revenue: 152310000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -93% 2025

Net margin -80.2% 2025

Free cash flow margin -90.8% 2025

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20182018-12-31	Operating margin	-138.5%	Operating Income: -21811000 Open source Revenue: 15753000 Open source
20192019-12-31	Operating margin	-122.7%	Operating Income: -25513000 Open source Revenue: 20789000 Open source
20202020-12-31	Operating margin	-749.8%	Operating Income: -71524000 Open source Revenue: 9539000 Open source
20212021-12-31	Operating margin	-1,641.3%	Operating Income: -202852000 Open source Revenue: 12359000 Open source
20222022-12-31	Operating margin	5.9%	Operating Income: 12177000 Open source Revenue: 205999000 Open source
20232023-12-31	Operating margin	-46.9%	Operating Income: -78205000 Open source Revenue: 166799000 Open source
20242024-12-31	Operating margin	-62.8%	Operating Income: -95669000 Open source Revenue: 152310000 Open source
20252025-12-31	Operating margin	-93%	Operating Income: -76260000 Open source Revenue: 82031000 Open source
20182018-12-31	Net margin	-138.3%	Net Income: -21785000 Open source Revenue: 15753000 Open source
20192019-12-31	Net margin	-125%	Net Income: -25991000 Open source Revenue: 20789000 Open source
20202020-12-31	Net margin	-756.3%	Net Income: -72148000 Open source Revenue: 9539000 Open source
20212021-12-31	Net margin	-1,648%	Net Income: -203674000 Open source Revenue: 12359000 Open source
20222022-12-31	Net margin	4.5%	Net Income: 9349000 Open source Revenue: 205999000 Open source
20232023-12-31	Net margin	-17.8%	Net Income: -29725000 Open source Revenue: 166799000 Open source
20242024-12-31	Net margin	-53.1%	Net Income: -80941000 Open source Revenue: 152310000 Open source
20252025-12-31	Net margin	-80.2%	Net Income: -65783000 Open source Revenue: 82031000 Open source
20182018-12-31	Free cash flow margin	-141.2%	Revenue: 15753000 Open source Operating Cash Flow: -20760000 Open source Capital Expenditure: 1478000 Open source
20192019-12-31	Free cash flow margin	-34.9%	Revenue: 20789000 Open source Operating Cash Flow: -6445000 Open source Capital Expenditure: 818000 Open source
20202020-12-31	Free cash flow margin	-467.6%	Revenue: 9539000 Open source Operating Cash Flow: -42861000 Open source Capital Expenditure: 1742000 Open source
20212021-12-31	Free cash flow margin	-1,120.2%	Revenue: 12359000 Open source Operating Cash Flow: -135043000 Open source Capital Expenditure: 3406000 Open source
20222022-12-31	Free cash flow margin	11.8%	Revenue: 205999000 Open source Operating Cash Flow: 31993000 Open source Capital Expenditure: 7726000 Open source
20232023-12-31	Free cash flow margin	-12.6%	Revenue: 166799000 Open source Operating Cash Flow: -18099000 Open source Capital Expenditure: 2901000 Open source
20242024-12-31	Free cash flow margin	-39.7%	Revenue: 152310000 Open source Operating Cash Flow: -59747000 Open source Capital Expenditure: 648000 Open source
20252025-12-31	Free cash flow margin	-90.8%	Revenue: 82031000 Open source Operating Cash Flow: -74271000 Open source Capital Expenditure: 230000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -74.3M 2025

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20182018-12-31	Operating cash flow	-20760000	Operating Cash Flow: -20760000 Open source
20192019-12-31	Operating cash flow	-6445000	Operating Cash Flow: -6445000 Open source
20202020-12-31	Operating cash flow	-42861000	Operating Cash Flow: -42861000 Open source
20212021-12-31	Operating cash flow	-135043000	Operating Cash Flow: -135043000 Open source
20222022-12-31	Operating cash flow	31993000	Operating Cash Flow: 31993000 Open source
20232023-12-31	Operating cash flow	-18099000	Operating Cash Flow: -18099000 Open source
20242024-12-31	Operating cash flow	-59747000	Operating Cash Flow: -59747000 Open source
20252025-12-31	Operating cash flow	-74271000	Operating Cash Flow: -74271000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -74.5M 2025

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20182018-12-31	Free cash flow	-22238000	Operating Cash Flow: -20760000 Open source Capital Expenditure: 1478000 Open source
20192019-12-31	Free cash flow	-7263000	Operating Cash Flow: -6445000 Open source Capital Expenditure: 818000 Open source
20202020-12-31	Free cash flow	-44603000	Operating Cash Flow: -42861000 Open source Capital Expenditure: 1742000 Open source
20212021-12-31	Free cash flow	-138449000	Operating Cash Flow: -135043000 Open source Capital Expenditure: 3406000 Open source
20222022-12-31	Free cash flow	24267000	Operating Cash Flow: 31993000 Open source Capital Expenditure: 7726000 Open source
20232023-12-31	Free cash flow	-21000000	Operating Cash Flow: -18099000 Open source Capital Expenditure: 2901000 Open source
20242024-12-31	Free cash flow	-60395000	Operating Cash Flow: -59747000 Open source Capital Expenditure: 648000 Open source
20252025-12-31	Free cash flow	-74501000	Operating Cash Flow: -74271000 Open source Capital Expenditure: 230000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

21.1% 2025

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20182018-12-31	Liabilities / assets	69.1%	Total Liabilities: 30556000 Open source Total Assets: 44198000 Open source
20192019-12-31	Liabilities / assets	68.6%	Total Liabilities: 56351000 Open source Total Assets: 82143000 Open source
20202020-12-31	Liabilities / assets	16.8%	Total Liabilities: 79903000 Open source Total Assets: 476456000 Open source
20212021-12-31	Liabilities / assets	41.9%	Total Liabilities: 164603000 Open source Total Assets: 392814000 Open source
20222022-12-31	Liabilities / assets	40%	Total Liabilities: 180075000 Open source Total Assets: 450387000 Open source
20232023-12-31	Liabilities / assets	35.1%	Total Liabilities: 150889000 Open source Total Assets: 429402000 Open source
20242024-12-31	Liabilities / assets	30%	Total Liabilities: 103091000 Open source Total Assets: 344069000 Open source
20252025-12-31	Liabilities / assets	21.1%	Total Liabilities: 57163000 Open source Total Assets: 271148000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

6.64× 2025

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20182018-12-31	Current assets / current liabilities	3.33×	Current Assets: 41828000 Open source Current Liabilities: 12577000 Open source
20192019-12-31	Current assets / current liabilities	3.48×	Current Assets: 74290000 Open source Current Liabilities: 21324000 Open source
20202020-12-31	Current assets / current liabilities	9.45×	Current Assets: 467789000 Open source Current Liabilities: 49521000 Open source
20212021-12-31	Current assets / current liabilities	3.81×	Current Assets: 378961000 Open source Current Liabilities: 99537000 Open source
20222022-12-31	Current assets / current liabilities	3.18×	Current Assets: 403333000 Open source Current Liabilities: 126984000 Open source
20232023-12-31	Current assets / current liabilities	4.72×	Current Assets: 386590000 Open source Current Liabilities: 81989000 Open source
20242024-12-31	Current assets / current liabilities	4.67×	Current Assets: 305979000 Open source Current Liabilities: 65489000 Open source
20252025-12-31	Current assets / current liabilities	6.64×	Current Assets: 241446000 Open source Current Liabilities: 36379000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2018 2018-01-01 – 2018-12-31	−USD 21.79 million Exact value Exact value: -21785000 USD 2018-01-01 – 2018-12-31: -21785000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Arcturus Therapeutics Holdings Inc. · 2018-12-31 Arcturus Therapeutics Holdings Inc. (edgar:1768224) Net Income: -21785000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1768224/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -21785000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1768224/000156459021009872/arct-10k_20201231.htm#1882702 Filing: 000156459021009872 The citation records this snapshot. The page link may show a newer release later.	−USD 20.76 million Exact value Exact value: -20760000 USD 2018-01-01 – 2018-12-31: -20760000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Arcturus Therapeutics Holdings Inc. · 2018-12-31 Arcturus Therapeutics Holdings Inc. (edgar:1768224) Operating Cash Flow: -20760000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1768224/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -20760000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1768224/000156459021009872/arct-10k_20201231.htm#1950093 Filing: 000156459021009872 The citation records this snapshot. The page link may show a newer release later.	USD 1.48 million Exact value Exact value: 1478000 USD 2018-01-01 – 2018-12-31: 1478000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Arcturus Therapeutics Holdings Inc. · 2018-12-31 Arcturus Therapeutics Holdings Inc. (edgar:1768224) Capital Expenditure: 1478000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1768224/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1478000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1768224/000156459021009872/arct-10k_20201231.htm#1960903 Filing: 000156459021009872 The citation records this snapshot. The page link may show a newer release later.	−USD 22.24 million Calculation and evidence -20760000 − 1478000 USD Exact free cash flow: -22238000 USD 2018-01-01 – 2018-12-31: -20760000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 1478000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Arcturus Therapeutics Holdings Inc. · 2018-12-31 Arcturus Therapeutics Holdings Inc. (edgar:1768224) Free cash flow: -22238000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1768224?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -20760000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1768224/000156459021009872/arct-10k_20201231.htm#1950093 Filing: 000156459021009872 Input fundies:CapitalExpenditure: 1478000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1768224/000156459021009872/arct-10k_20201231.htm#1960903 Filing: 000156459021009872 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 25.99 million Exact value Exact value: -25991000 USD 2019-01-01 – 2019-12-31: -25991000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Arcturus Therapeutics Holdings Inc. · 2019-12-31 Arcturus Therapeutics Holdings Inc. (edgar:1768224) Net Income: -25991000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1768224/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -25991000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1768224/000156459022007832/arct-10k_20211231.htm#1809170 Filing: 000156459022007832 The citation records this snapshot. The page link may show a newer release later.	−USD 6.45 million Exact value Exact value: -6445000 USD 2019-01-01 – 2019-12-31: -6445000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Arcturus Therapeutics Holdings Inc. · 2019-12-31 Arcturus Therapeutics Holdings Inc. (edgar:1768224) Operating Cash Flow: -6445000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1768224/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -6445000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1768224/000156459022007832/arct-10k_20211231.htm#1887426 Filing: 000156459022007832 The citation records this snapshot. The page link may show a newer release later.	USD 818,000 Exact value Exact value: 818000 USD 2019-01-01 – 2019-12-31: 818000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Arcturus Therapeutics Holdings Inc. · 2019-12-31 Arcturus Therapeutics Holdings Inc. (edgar:1768224) Capital Expenditure: 818000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1768224/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 818000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1768224/000156459022007832/arct-10k_20211231.htm#1898264 Filing: 000156459022007832 The citation records this snapshot. The page link may show a newer release later.	−USD 7.26 million Calculation and evidence -6445000 − 818000 USD Exact free cash flow: -7263000 USD 2019-01-01 – 2019-12-31: -6445000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 818000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Arcturus Therapeutics Holdings Inc. · 2019-12-31 Arcturus Therapeutics Holdings Inc. (edgar:1768224) Free cash flow: -7263000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1768224?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -6445000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1768224/000156459022007832/arct-10k_20211231.htm#1887426 Filing: 000156459022007832 Input fundies:CapitalExpenditure: 818000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1768224/000156459022007832/arct-10k_20211231.htm#1898264 Filing: 000156459022007832 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 72.15 million Exact value Exact value: -72148000 USD 2020-01-01 – 2020-12-31: -72148000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Arcturus Therapeutics Holdings Inc. · 2020-12-31 Arcturus Therapeutics Holdings Inc. (edgar:1768224) Net Income: -72148000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1768224/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -72148000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1768224/000156459022007832/arct-10k_20211231.htm#1807415 Filing: 000156459022007832 The citation records this snapshot. The page link may show a newer release later.	−USD 42.86 million Exact value Exact value: -42861000 USD 2020-01-01 – 2020-12-31: -42861000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Arcturus Therapeutics Holdings Inc. · 2020-12-31 Arcturus Therapeutics Holdings Inc. (edgar:1768224) Operating Cash Flow: -42861000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1768224/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -42861000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1768224/000156459022007832/arct-10k_20211231.htm#1885571 Filing: 000156459022007832 The citation records this snapshot. The page link may show a newer release later.	USD 1.74 million Exact value Exact value: 1742000 USD 2020-01-01 – 2020-12-31: 1742000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Arcturus Therapeutics Holdings Inc. · 2020-12-31 Arcturus Therapeutics Holdings Inc. (edgar:1768224) Capital Expenditure: 1742000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1768224/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1742000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1768224/000156459022007832/arct-10k_20211231.htm#1896485 Filing: 000156459022007832 The citation records this snapshot. The page link may show a newer release later.	−USD 44.6 million Calculation and evidence -42861000 − 1742000 USD Exact free cash flow: -44603000 USD 2020-01-01 – 2020-12-31: -42861000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 1742000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Arcturus Therapeutics Holdings Inc. · 2020-12-31 Arcturus Therapeutics Holdings Inc. (edgar:1768224) Free cash flow: -44603000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1768224?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -42861000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1768224/000156459022007832/arct-10k_20211231.htm#1885571 Filing: 000156459022007832 Input fundies:CapitalExpenditure: 1742000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1768224/000156459022007832/arct-10k_20211231.htm#1896485 Filing: 000156459022007832 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 203.67 million Exact value Exact value: -203674000 USD 2021-01-01 – 2021-12-31: -203674000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Arcturus Therapeutics Holdings Inc. · 2021-12-31 Arcturus Therapeutics Holdings Inc. (edgar:1768224) Net Income: -203674000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1768224/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -203674000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1768224/000095017024031156/arct-20231231.htm#1741569 Filing: 000095017024031156 The citation records this snapshot. The page link may show a newer release later.	−USD 135.04 million Exact value Exact value: -135043000 USD 2021-01-01 – 2021-12-31: -135043000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Arcturus Therapeutics Holdings Inc. · 2021-12-31 Arcturus Therapeutics Holdings Inc. (edgar:1768224) Operating Cash Flow: -135043000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1768224/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -135043000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1768224/000095017024031156/arct-20231231.htm#1807539 Filing: 000095017024031156 The citation records this snapshot. The page link may show a newer release later.	USD 3.41 million Exact value Exact value: 3406000 USD 2021-01-01 – 2021-12-31: 3406000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Arcturus Therapeutics Holdings Inc. · 2021-12-31 Arcturus Therapeutics Holdings Inc. (edgar:1768224) Capital Expenditure: 3406000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1768224/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3406000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1768224/000095017024031156/arct-20231231.htm#1814349 Filing: 000095017024031156 The citation records this snapshot. The page link may show a newer release later.	−USD 138.45 million Calculation and evidence -135043000 − 3406000 USD Exact free cash flow: -138449000 USD 2021-01-01 – 2021-12-31: -135043000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 3406000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Arcturus Therapeutics Holdings Inc. · 2021-12-31 Arcturus Therapeutics Holdings Inc. (edgar:1768224) Free cash flow: -138449000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1768224?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -135043000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1768224/000095017024031156/arct-20231231.htm#1807539 Filing: 000095017024031156 Input fundies:CapitalExpenditure: 3406000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1768224/000095017024031156/arct-20231231.htm#1814349 Filing: 000095017024031156 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	USD 9.35 million Exact value Exact value: 9349000 USD 2022-01-01 – 2022-12-31: 9349000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Arcturus Therapeutics Holdings Inc. · 2022-12-31 Arcturus Therapeutics Holdings Inc. (edgar:1768224) Net Income: 9349000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1768224/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: 9349000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1768224/000095017025034787/arct-20241231.htm#2922923 Filing: 000095017025034787 The citation records this snapshot. The page link may show a newer release later.	USD 31.99 million Exact value Exact value: 31993000 USD 2022-01-01 – 2022-12-31: 31993000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Arcturus Therapeutics Holdings Inc. · 2022-12-31 Arcturus Therapeutics Holdings Inc. (edgar:1768224) Operating Cash Flow: 31993000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1768224/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 31993000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1768224/000095017025034787/arct-20241231.htm#1925202 Filing: 000095017025034787 The citation records this snapshot. The page link may show a newer release later.	USD 7.73 million Exact value Exact value: 7726000 USD 2022-01-01 – 2022-12-31: 7726000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Arcturus Therapeutics Holdings Inc. · 2022-12-31 Arcturus Therapeutics Holdings Inc. (edgar:1768224) Capital Expenditure: 7726000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1768224/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 7726000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1768224/000095017025034787/arct-20241231.htm#1933816 Filing: 000095017025034787 The citation records this snapshot. The page link may show a newer release later.	USD 24.27 million Calculation and evidence 31993000 − 7726000 USD Exact free cash flow: 24267000 USD 2022-01-01 – 2022-12-31: 31993000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 7726000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Arcturus Therapeutics Holdings Inc. · 2022-12-31 Arcturus Therapeutics Holdings Inc. (edgar:1768224) Free cash flow: 24267000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1768224?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 31993000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1768224/000095017025034787/arct-20241231.htm#1925202 Filing: 000095017025034787 Input fundies:CapitalExpenditure: 7726000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1768224/000095017025034787/arct-20241231.htm#1933816 Filing: 000095017025034787 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 29.73 million Exact value Exact value: -29725000 USD 2023-01-01 – 2023-12-31: -29725000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Arcturus Therapeutics Holdings Inc. · 2023-12-31 Arcturus Therapeutics Holdings Inc. (edgar:1768224) Net Income: -29725000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1768224/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -29725000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1768224/000119312526088391/arct-20251231.htm#3012579 Filing: 000119312526088391 The citation records this snapshot. The page link may show a newer release later.	−USD 18.1 million Exact value Exact value: -18099000 USD 2023-01-01 – 2023-12-31: -18099000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Arcturus Therapeutics Holdings Inc. · 2023-12-31 Arcturus Therapeutics Holdings Inc. (edgar:1768224) Operating Cash Flow: -18099000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1768224/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -18099000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1768224/000119312526088391/arct-20251231.htm#1931451 Filing: 000119312526088391 The citation records this snapshot. The page link may show a newer release later.	USD 2.9 million Exact value Exact value: 2901000 USD 2023-01-01 – 2023-12-31: 2901000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Arcturus Therapeutics Holdings Inc. · 2023-12-31 Arcturus Therapeutics Holdings Inc. (edgar:1768224) Capital Expenditure: 2901000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1768224/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2901000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1768224/000119312526088391/arct-20251231.htm#1940725 Filing: 000119312526088391 The citation records this snapshot. The page link may show a newer release later.	−USD 21 million Calculation and evidence -18099000 − 2901000 USD Exact free cash flow: -21000000 USD 2023-01-01 – 2023-12-31: -18099000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 2901000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Arcturus Therapeutics Holdings Inc. · 2023-12-31 Arcturus Therapeutics Holdings Inc. (edgar:1768224) Free cash flow: -21000000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1768224?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -18099000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1768224/000119312526088391/arct-20251231.htm#1931451 Filing: 000119312526088391 Input fundies:CapitalExpenditure: 2901000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1768224/000119312526088391/arct-20251231.htm#1940725 Filing: 000119312526088391 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−USD 80.94 million Exact value Exact value: -80941000 USD 2024-01-01 – 2024-12-31: -80941000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Arcturus Therapeutics Holdings Inc. · 2024-12-31 Arcturus Therapeutics Holdings Inc. (edgar:1768224) Net Income: -80941000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1768224/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -80941000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1768224/000119312526088391/arct-20251231.htm#3010722 Filing: 000119312526088391 The citation records this snapshot. The page link may show a newer release later.	−USD 59.75 million Exact value Exact value: -59747000 USD 2024-01-01 – 2024-12-31: -59747000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Arcturus Therapeutics Holdings Inc. · 2024-12-31 Arcturus Therapeutics Holdings Inc. (edgar:1768224) Operating Cash Flow: -59747000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1768224/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -59747000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1768224/000119312526088391/arct-20251231.htm#1929700 Filing: 000119312526088391 The citation records this snapshot. The page link may show a newer release later.	USD 648,000 Exact value Exact value: 648000 USD 2024-01-01 – 2024-12-31: 648000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Arcturus Therapeutics Holdings Inc. · 2024-12-31 Arcturus Therapeutics Holdings Inc. (edgar:1768224) Capital Expenditure: 648000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1768224/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 648000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1768224/000119312526088391/arct-20251231.htm#1938986 Filing: 000119312526088391 The citation records this snapshot. The page link may show a newer release later.	−USD 60.4 million Calculation and evidence -59747000 − 648000 USD Exact free cash flow: -60395000 USD 2024-01-01 – 2024-12-31: -59747000 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 648000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Arcturus Therapeutics Holdings Inc. · 2024-12-31 Arcturus Therapeutics Holdings Inc. (edgar:1768224) Free cash flow: -60395000 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1768224?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -59747000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1768224/000119312526088391/arct-20251231.htm#1929700 Filing: 000119312526088391 Input fundies:CapitalExpenditure: 648000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1768224/000119312526088391/arct-20251231.htm#1938986 Filing: 000119312526088391 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	−USD 65.78 million Exact value Exact value: -65783000 USD 2025-01-01 – 2025-12-31: -65783000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Arcturus Therapeutics Holdings Inc. · 2025-12-31 Arcturus Therapeutics Holdings Inc. (edgar:1768224) Net Income: -65783000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1768224/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: -65783000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1768224/000119312526088391/arct-20251231.htm#3008865 Filing: 000119312526088391 The citation records this snapshot. The page link may show a newer release later.	−USD 74.27 million Exact value Exact value: -74271000 USD 2025-01-01 – 2025-12-31: -74271000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Arcturus Therapeutics Holdings Inc. · 2025-12-31 Arcturus Therapeutics Holdings Inc. (edgar:1768224) Operating Cash Flow: -74271000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1768224/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -74271000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1768224/000119312526088391/arct-20251231.htm#1927949 Filing: 000119312526088391 The citation records this snapshot. The page link may show a newer release later.	USD 230,000 Exact value Exact value: 230000 USD 2025-01-01 – 2025-12-31: 230000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Arcturus Therapeutics Holdings Inc. · 2025-12-31 Arcturus Therapeutics Holdings Inc. (edgar:1768224) Capital Expenditure: 230000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1768224/explain?concept=fundies%3ACapitalExpenditure&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 230000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1768224/000119312526088391/arct-20251231.htm#1937247 Filing: 000119312526088391 The citation records this snapshot. The page link may show a newer release later.	−USD 74.5 million Calculation and evidence -74271000 − 230000 USD Exact free cash flow: -74501000 USD 2025-01-01 – 2025-12-31: -74271000 USD · Inspect Operating Cash Flow · Source 2025-01-01 – 2025-12-31: 230000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Arcturus Therapeutics Holdings Inc. · 2025-12-31 Arcturus Therapeutics Holdings Inc. (edgar:1768224) Free cash flow: -74501000 USD Concept: free-cash-flow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1768224?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -74271000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1768224/000119312526088391/arct-20251231.htm#1927949 Filing: 000119312526088391 Input fundies:CapitalExpenditure: 230000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1768224/000119312526088391/arct-20251231.htm#1937247 Filing: 000119312526088391 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

36 filings · 2,072 latest values · 2,072 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001768224, 1768224, ARCT, edgar:1768224

Also known as ARCTURUS THERAPEUTICS HOLDINGS INC., Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2025 2025-01-01 – 2025-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation